Piramal Pharma Limited (PPLPHARMA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Piramal Pharma Limited (PPLPHARMA) has a cash flow conversion efficiency ratio of 0.110x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs8.90 Billion ≈ $96.22 Million USD) by net assets (Rs80.74 Billion ≈ $873.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Piramal Pharma Limited worth for the company's overall valuation and market capitalisation.
Piramal Pharma Limited - Cash Flow Conversion Efficiency Trend (2021–2026)
This chart illustrates how Piramal Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Piramal Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Piramal Pharma Limited ranked by their cash flow conversion efficiency. Explore PPLPHARMA cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aperam SA
MC:APAM
|
0.042x |
|
OceanaGold Corporation
F:RQQ
|
0.106x |
|
XJ Electric Co Ltd
SHE:000400
|
0.059x |
|
Nanjing Tanker Corp
SHG:601975
|
0.041x |
|
KINGSOFT C.H.LTD. DL-001
F:KS70
|
0.112x |
|
Seek Ltd
AU:SEK
|
0.119x |
|
Vista Energy S.A.B. de C.V.
BA:VIST
|
0.280x |
|
National Storage REIT
AU:NSR
|
0.018x |
Annual Cash Flow Conversion Efficiency for Piramal Pharma Limited (2021–2026)
The table below shows the annual cash flow conversion efficiency of Piramal Pharma Limited from 2021 to 2026. View PPLPHARMA share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs81.63 Billion ≈ $882.76 Million |
Rs14.00 Billion ≈ $151.36 Million |
0.171x | +56.13% |
| 2025-03-31 | Rs81.25 Billion ≈ $878.74 Million |
Rs8.92 Billion ≈ $96.50 Million |
0.110x | -13.51% |
| 2024-03-31 | Rs79.11 Billion ≈ $855.58 Million |
Rs10.05 Billion ≈ $108.64 Million |
0.127x | +77.74% |
| 2023-03-31 | Rs67.73 Billion ≈ $732.53 Million |
Rs4.84 Billion ≈ $52.33 Million |
0.071x | +87.46% |
| 2022-03-31 | Rs66.97 Billion ≈ $724.21 Million |
Rs2.55 Billion ≈ $27.60 Million |
0.038x | +350.09% |
| 2021-03-31 | Rs41.01 Billion ≈ $443.47 Million |
Rs347.20 Million ≈ $3.75 Million |
0.008x | -- |
About Piramal Pharma Limited
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, devel… Read more